References
- Šegedin B, Merlo S, Smrkolj Š, Bebar S, Blatnik A, Cerar O, et al. [Recommendations in management of endometrial cancer]. [Slovenian]. Institute of Oncology Ljubljana: Radiotherapy and Oncology Society: Ljubljana; 2018.
- Cancer in Slovenia 2017. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Slovenian Cancer Registry; 2020.
- Corzo C, Barrientos Santillan N, Westin SN, Ramirez PT. Updates on conservative management of endometrial cancer. J Minim Invasive Gynecol 2018; 25: 308-13. doi: 10.1016/j.jmig.2017.07.022
- Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 2016; 27: 16-41. doi: 10.1093/annonc/mdv484
- Neri M, Peiretti M, Melis GB, Piras B, Vallerino V, Paoletti AM, et al. Systemic therapy for the treatment of endometrial cancer. Expert Opin Pharmacother 2019; 20: 2019-32. doi: 10.1080/14656566.2019.1654996
- Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, Obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers 2014; 29: e21-9. doi: 10.5301/jbm.5000047
- Malik TY, Chishti U, Aziz AB, Sheikh I. Comparison of risk factors and survival of type 1 and type II endometrial cancers. Pak J Med Sci 2016; 32: 886-90. doi: 10.12669/pjms.324.9265
- Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ 2010; 340: c927. doi: 10.1136/bmj.c927
- Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607-18. doi: 10.1200/JCO.2012.48.2596
- Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. 4th edition. Lyon: International Agency for Research on Cancer, World Health Organization; 2014.
- Arko D, Kozar N, Rmuš M, Takač I. The reliability of preoperative determination of tumour grade in endometrial cancer. Zdrav Vest 2018; 87: 167-75. doi: 10.6016/ZdravVestn.2495
- Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, et al. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin 2019; 69: 258-79. doi: 10.3322/caac.21561
- Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 2016; 15: 423-7. doi: 10.1007/s10689-016-9893-5
- Hinchcliff EM, Bednar EM, Lu KH, Rauh-Hain JA. Disparities in gynecologic cancer genetics evaluation. Gynecol Oncol 2019; 153: 184-91. doi: 10.1016/j.ygyno.2019.01.024
- National Comprehensive Cancer Network. Genetic/familial high-risk assessment: colorectal: Version 1.2020 - July 21, 2020. [cited 2021 Jan 11]. Available at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf
- Daniels MS, Lu KH. Genetic predisposition in gynecologic cancers. Semin Oncol 2016; 43: 543-7. doi: 10.1053/j.seminoncol.2016.08.005
- Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev 2010; 36: 577-83. doi: 10.1016/j.ctrv.2010.04.002
- Dovnik A, Crnobrnja B, Zegura B, Takac I, Pakiz M. Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage. Radiol Oncol 2016; 51: 88-93. doi: 10.1515/ raon-2016-0035
- Chen J, Clark LH, Kong WM, Yan Z, Han C, Zhao H, et al. Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma? PLoS One 2017; 12: e0174226. doi: 10.1371/journal.pone.0174226
- Biewenga P, de Blok S, Birnie E. Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings? Gynecol Oncol 2004; 93: 194-8. doi: 10.1515/raon-2016-0035
- Falcone F, Balbi G, Di Martino L, Grauso F, Salzillo ME, Messalli EM. Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm. Med Sci Monit 2014; 20: 1298-313. doi: 10.12659/ MSM.890478
- Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol 2012; 30: 695-700. doi: 10.1200/JCO.2011.38.8645
- Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2012; 207: 94-100. doi: 10.1016/j.ajog.2012.01.010
- Rabinovich A. Minimally invasive surgery for endometrial cancer. Curr Opin Obstet Gynecol 2015; 27: 302-7. doi: 10.1097/GCO.0000000000000187
- Bourgin C, Lambaudie E, Houvenaeghel G, Foucher F, Levêque J, Lavoué V. Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer management. Eur J Surg Oncol 2017; 43: 703-9. doi: 10.1016/j.ejso.2016.10.022
- Biler A, Solmaz U, Erkilinc S, Gokcu M, Bagci M, Temel O, et al. Analysis of endometrial carcinoma in young women at a high-volume cancer center. Int J Surg 2017; 44: 185-90. doi: 10.1016/j.ijsu.2017.06.083
- Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertil Steril 2013; 100: 782-7. doi: 10.1016/j.fertnstert.2013.05.032
- Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J. Survival impact of ovarian preservation on women with early-stage endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 2017; 27: 77-84. doi: 10.1097/ IGC.0000000000000857
- Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216: 459-76.e10. doi: 10.1016/j.ajog.2016.11.1033
- Bedyńska M, Szewczyk G, Klepacka T, Sachadel K, Maciejewski T, Szukiewicz D, et al. Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method. Arch Gynecol Obstet 2019; 299: 1373-84. doi: 10.1007/s00404-019-05063-6
- Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial) : a multicentre, prospective, cohort study. Lancet Oncol 2017; 18: 384-92. doi: 10.1016/S1470-2045(17)30068-2
- Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 2012; 127: 5-10. doi: 10.1016/j.ygyno.2012.06.035
- Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 2014; 133: 216-20. doi: 10.1016/j.ygyno.2014.02.011
- Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102: 92-7. doi: 10.1097/01.ogx.0000238643.54754.6a
- Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 2008; 198: 457. e1-5; discussion 457.e5-6. doi: 10.1016/j.ajog.2008.01.010
- Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-8. doi: 10.1016/j.ygyno.2008.01.023
- AlHilli MM, Mariani A. The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol 2013; 18: 193-9. doi: 10.1007/s10147-013-0528-7
- Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, Leitao MM. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol 2011; 122: 608-11. doi: 10.1016/j.ygyno.2011.05.020
- van der Steen-Banasik E, Christiaens M, Shash E, Coens C, Casado A, Herrera FG, et al. Systemic review: radiation therapy alone in medical non-operable endometrial carcinoma. Eur J Cancer 2016; 65: 172-81. doi: 10.1016/j. ejca.2016.07.005
- Uccella S, Falcone F, Greggi S, Fanfani F, De Iaco P, Corrado G, et al. Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study. J Gynecol Oncol 2018; 29: e100. doi: 10.3802/jgo.2018.29.e100
- Muallem MZ, Sehouli J, Richter R, Babayeva A, Gasimli K, Parashkevova A. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer. Int J Gynecol Cancer 2020; 30: 62-6. doi: 10.1136/ijgc-2019-000778
- Lin YJ, Hu YW, Twu NF, Liu YM. The role of adjuvant radiotherapy in stage I endometrial cancer: a single-institution outcome. Taiwan J Obstet Gynecol 2019; 58: 604-9. doi: 10.1016/j.tjog.2019.07.005
- Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65. doi: 10.1016/0090-8258(91)90086-k
- Creasman W, Odicino F, Maisonneuve P, Quinn M, Beller U, Benedet J, et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 2006; 95(Suppl 1): S105-43. doi: 10.1016/S0020-7292(06)60031-3
- Rovirosa Á, Cortés KS, Ascaso C, Glickman A, Valdés S, Herreros A, et al. Are endometrial cancer radiotherapy results age related? Clin Transl Oncol 2018; 20: 1416-21. doi: 10.1007/s12094-018-1872-x
- Bestvina CM, Fleming GF. Chemotherapy for endometrial cancer in adjuvant and advanced disease settings. Oncologist 2016; 21: 1250-9. doi: 10.1634/ theoncologist.2016-0062
- Gressel GM, Parkash V, Pal L. Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer. Int J Gynaecol Obstet 2015; 131: 234-9. doi: 10.1016/j. ijgo.2015.06.031
- Kalogiannidis I, Agorastos T. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma. J Obstet Gynaecol 2011; 31: 13-7. doi: 10.3109/01443615.2010.532249
- Carneiro MM, Lamaita RM, Ferreira MCF, Silva-Filho AL. Fertility-preservation in endometrial cancer: is it safe? Review of the literature. JBRA Assist Reprod 2016; 20: 232-9. doi: 10.5935/1518-0557.20160045
- Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011; 205: 103-10. doi: 10.1016/j.ajog.2011.01.025
- Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Frigerio L, et al. Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol 2016; 37: 6-12. PMID: 27048101
- Zivanovic O, Carter J, Kauff ND, Barakat RR. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecol Oncol 2009; 115: 504-9. doi: 10.1016/j.ygyno.2009.08.011
- Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, et al. Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device: Obstet Gynecol 2018; 131: 109-16. doi: 10.1097/AOG.0000000000002390
- Aslam RW, Pye KL, Rai TK, Hall B, Timmis LJ, Yeo ST, et al. Follow-up strategies for women with endometrial cancer after primary treatment. Cochrane Db Syst Rev 2016. doi: 10.1002/14651858.CD012386